Just in time for the Annual Meeting of the American Academy of Ophthalmology (AAO 2018) in Chicago, OD-OS is launching a new widefield objective which brings non-contact panretinal photocoagulation with access to the far periphery (ora serrata) to the Navilas® 577s Laser System. The new option for peripheral treatments can further enhance compliance of sensitive patients and therefore allow for more comfortable PRP sessions.

This addition makes Navilas® the only retinal laser which allows for navigated focal and peripheral treatments (single spots and pattern) without a contact lens. The system supports digital pre-planning and computer-assisted delivery of laser spots thanks to its integrated eye tracking technology.

For a demo of navigated non-contact PRP treatment, visit OD-OS at the AAO in Chicago:
- October 26: #44 at the AAO Retina Subspecialty Day
- October 27-30: #740 at the AAO main exhibition

The non-contact widefield objective will become available to Navilas® 577s users at the end of this year.
Regional availability may vary.

Watch video at: www.od-os.com/prp

Here is what Navilas® users, who recently tested the non-contact widefield objective in clinical practice are saying:

Dr. Gregor Eberlein, University Clinic Augsburg, Germany: “My experience of extending comfortable non-contact treatment to the periphery was really good. It can be a great option for retinopexy and PRP treatments of patients averse to the contact lens.”

Dr. Jean-Christophe Ramel, France: “The field of view of the non-contact widefield objective is really amazing. I had a perfect view of a retinal tear in the far periphery.”

Dr. Stephan Deichelbohrer, St. Vincentius-Kliniken Karlsruhe, Germany: “The non-contact widefield objective allows me to apply more spots in a single session as the cornea remains clear throughout the whole procedure – also by letting the patient lean back and blink for a moment. When using a standard contact lens the image quality may degrade due to superficial staining of the cornea.”

Ulrike Rahn, Clinical Project Manager at OD-OS: “This is a result from a successful collaboration with our Navilas® customers at CHI de Créteil in France that our development team has now turned into another treatment option for our Navilas® 577s Laser.” 

Listen to Navilas® users at AAO:
- Q&A sessions at OD-OS #740 on October 27/28 at 10:00 am – more at: www.od-os.com/aao2018
- Talk by our user Dr. Jay Chhablani at Retina Subspecialty Day covering current knowledge on microsecond pulsing laser treatment (RET07, Friday, Oct 26, 11:39 am, Room: ARIE CROWN)

About Navilas®:  Navilas® laser systems enable physicians to digitally pre-plan the entire laser therapy on fundus images as well as on third-party diagnostic images, and to precisely execute this therapy plan with the help of computerized image guidance.

About OD-OS: OD-OS GmbH is a privately-held medical device company founded in 2008 with offices in Teltow, Germany, and Irvine, CA. www.od-os.com

For further information, please contact:
Stefanie Gehrke, Director Marketing | stefanie.gehrke@od-os.com, +49 (172) 3808 537
OD-OS GmbH | Warthestr. 21 | 14513 Teltow | German